Momenta

Press Releases

All Releases
View Summary Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting
Apr 20, 2015
PDF 16.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Data Presentations on Glatopa(TM) (glatiramer acetate injection) at the American Academy of Neurology's (AAN) 2015 Annual Meeting
Apr 17, 2015
PDF 14.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Conference Call Details Regarding FDA Approval for Glatopa(TM) (glatiramer acetate injection)
Apr 16, 2015
PDF 16.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Apr 16, 2015
PDF 20.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of First Quarter 2015 Financial Results Conference Call and Webcast
Apr 15, 2015
PDF 13.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Publication Revealing Development of a Novel Process to Generate High-Quality Hyper-sialylated IVIg Drug Candidate in PNAS
Mar 2, 2015
PDF 17.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at Cowen and Company's 35th Annual Health Care Conference
Feb 18, 2015
PDF 7.4 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results
Feb 17, 2015
PDF 25.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast
Feb 3, 2015
PDF 7.7 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Jan 29, 2015
PDF 7.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Supreme Court Decision to Remand Generic Copaxone(R) Case Back to CAFC
Jan 21, 2015
PDF 11.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals' Necuparanib Receives Fast Track Designation From the FDA for the Treatment of Patients With Metastatic Pancreatic Cancer
Dec 1, 2014
PDF 11.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R)
Dec 1, 2014
PDF 10.7 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at 2014 Deutsche Bank BioFEST
Nov 24, 2014
PDF 7.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences
Nov 6, 2014
PDF 7.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results
Nov 5, 2014
PDF 24.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast
Oct 22, 2014
PDF 7.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer
Oct 9, 2014
PDF 57.7 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Host 2014 R&D Day
Oct 2, 2014
PDF 9.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
Sep 17, 2014
PDF 7.1 KB Add to Briefcase
Showing 1-20 of 326 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase